Related Experiment Video
Updated: Sep 6, 2025
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Microglia in Parkinson's Disease
1Laboratory for Translational Neurodegeneration Research, Division of Neurobiology, Department of Neurology, Medical University of Innsbruck, Austria.
Abstract:
Microglia are the primary resident immune cells of the central nervous system. Neuropathological reports have identified augmented microglial activation in brains of patients with neurodegenerative disorders including Parkinson's disease (PD). Extensive research over the years has strengthened the current view on microglia as a player in the pathogenesis of PD and other α-synucleinopathies. In this review, we summarize key findings of the recent three years on microglia in PD with specific relevance to understanding its heterogeneity, dual nature, and specific interactions with pathological α-synuclein strains to mediate its clearance and spreading. This review provides evidence on the relevance of microglia as a putative biomarker and therapeutic target in PD and related disorders.
Insights
Microglia, the brain's immune cells, play a dual role in Parkinson's disease (PD) pathogenesis by clearing and spreading toxic alpha-synuclein. Understanding microglial heterogeneity offers new therapeutic targets for PD.
Area of Science:
- Neuroimmunology
- Neurodegeneration
- Central Nervous System (CNS) research
Background:
- Microglia are the primary immune cells in the CNS.
- Increased microglial activation is observed in neurodegenerative disorders like Parkinson's disease (PD).
- Microglia are increasingly recognized for their role in PD pathogenesis and alpha-synucleinopathies.
Purpose of the Study:
- To review recent findings (last 3 years) on microglia in PD.
- To elucidate microglial heterogeneity and their dual role in PD.
- To examine microglia's interaction with pathological alpha-synuclein.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of studies focusing on microglial function in PD.
- Synthesis of data on alpha-synuclein clearance and spreading mediated by microglia.
Main Results:
- Microglia exhibit significant heterogeneity in their activation states and functions in PD.
- Microglia demonstrate a dual role: mediating both clearance and propagation of pathological alpha-synuclein.
- Specific microglial interactions with alpha-synuclein strains are crucial for disease progression.
Conclusions:
- Microglia are central players in PD pathogenesis, influencing both disease initiation and progression.
- Microglial heterogeneity presents a complex but promising area for therapeutic intervention in PD.
- Microglia represent a potential biomarker and therapeutic target for Parkinson's disease and related disorders.
More Related Videos
07:54Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
11:19Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
Published on: August 18, 2022
Related Concept Videos
01:15Parkinson's Disease: Overview
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
01:37Neural Regulation